-VISIT OUR OTHER FORUMS- OB-GYN-L Ultrasound Ultrasound History Fibroid Forum Physicians-in-Training Tech Talk OBSTET-L (portuguese) OBGIN-L (spanish) Nursing

Re: Glyburide From: Elrod Darryl G MAJ 48 MDOS/SGOBO (Darryl.elrod@LAKENHEATH.AF.MIL) Wed Mar 23 13:23:38 2005 Messages sorted by: [ date ][ thread ][ subject ][ author ] Next message: R. Daniel Braun: "Re: uterine adhesions to post per. wall" Previous message: Steve & Eryl Raymond: "Re: uterine adhesions to post per. wall" Maybe in reply to: Lynn D. Montgomery, M.D.: "Glyburide" Next in thread: Lynn D. Montgomery, M.D.: "Re: Glyburide" Reply: Lynn D. Montgomery, M.D.: "Re: Glyburide" Reply: Garry E. Siegel, M.D.: "Re: Glyburide" Lynn, Do you test them as you would an A2 on insulin? Do you still recommend delivery at or about 39 weeks? Thanks, Glen ________________________________ From: ob-gyn-l@obgyn.net [mailto:ob-gyn-l@obgyn.net] On Behalf Of Lynn -- ________________________________ D. Montgomery, M.D. Sent: Wednesday, March 23, 2005 5:47 PM To: Multiple recipients of list OB-GYN-L Subject: Glyburide I have been using it for several years. The South Africans have been using the oral hypoglycemics for many years and have good data on them. In this country, Langer, et al, who was in San Antonio and now New York, did great work using a placental model and demonstrated its relative safety. I start out with 5 mg per day and increase to a max of 20 mg per day, then if further control is needed, change over to insulin. There is at least one paper recently where they added insulin to the Glyburide. I haven't done that. Interesting note on a couple of papers at the Society meeting last month that addressed Glyburide therapy was that there seemed to be an increased incidence of patients using Glyburide therapy developing preeclampsia late in pregnancy. Obviously small studies and difficult to sort through the issue that this subset of patients may be at increased risk of developing preeclampsia. The standard line fits: This needs to be looked at in a larger population. Lynn Lynn D. Montgomery, M.D. Maternal-Fetal Medicine, OB/GYN Rocky Mountain Women's Health 2835 Fort Missoula Rd., Suite 304 Missoula, Montana, 59804 406-549-0978 fax 406-549-0987 e-mail: apgar10@montanadsl.net Next message: R. Daniel Braun: "Re: uterine adhesions to post per. wall" Previous message: Steve & Eryl Raymond: "Re: uterine adhesions to post per. wall" Maybe in reply to: Lynn D. Montgomery, M.D.: "Glyburide" Next in thread: Lynn D. Montgomery, M.D.: "Re: Glyburide" Reply: Lynn D. Montgomery, M.D.: "Re: Glyburide" Reply: Garry E. Siegel, M.D.: "Re: Glyburide"

Return to

Mail a New Message to the Forum: ob-gyn-l@obgyn.net Forum Administrator: geffrey.klein@obgyn.net Report Technical Problems: webmaster@obgyn.net Last Updated: Thu Oct 2 04:47:59 2008

The American Medical Association is no longer designating CME hours for AMA Category II CME credit. However, physicians themselves may self designate learning activities as Category II CME credit hours if they feel it is of sufficient educational merit and meets the formal definitions of continuing medical education. OBGYN.net believes these interaction in this forum meets these criteria. For further information see the AMA web site.